Takeda Pharmaceutical Company reported new data today showing its Takeda immune drug TAK-881 performs as effectively as an already approved treatment in patients with primary immunodeficiency (PID).
India’s pharmaceutical sector is heading into a mixed March quarter, with drugmakers head into uneven Q4 as margins come under strain from US pricing pressure, loss of high-margin opportunities, and rising costs.
India has launched a nationwide childhood diabetes screening plan, aiming to improve early detection, ensure timely diabetes treatment, and provide long-term child healthcare across the country. The Centre’s new framework focuses on strengtheni...
In a major step forward for healthcare, All India Institute of Medical Sciences (AIIMS Delhi) has rolled out India’s first portable MRI system, bringing bedside brain imaging directly to patients and reshaping how critical care diagnosti...
India’s Revised Safety Norms are set to change how hospitals grow, with the Centre easing long-standing restrictions on building height. The Bureau of Indian Standards (BIS) has removed the 45-metre cap on hospital structures under the newly...
Aurobindo Pharma’s biosimilars arm CuraTeQ Biologics has secured a major regulatory milestone, as it wins Canada nod for its cancer biosimilar, marking a significant step in the company’s global expansion in oncology treatmen...
Bristol Myers beats quarterly profit estimates in its latest earnings report, driven by strong demand for its blood thinner and newer cancer treatments. The company posted adjusted earnings of USD 1.58 per share, topping analyst expectations...
The National Health Summit concluded today with a strong focus on Evidence-Based Health Reforms guided by findings from the 17th Common Review Mission (CRM) under the National Health Mission. The second day centered on technical discussions...
The Top Stories shaping the Pharma Industry right now show a clear shift—global deals, AI-led innovation, and policy clarity are driving momentum. From major acquisitions to breakthrough trials and public health moves, these updates reflect...
Zydus Lifesciences has expanded its presence in France healthcare market with a €700,000 acquisition of FBC Medical, a move that strengthens its position in the medical equipment distribution sector. The deal marks another step in the compan...
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")